TrialJournal of neuro-oncology2016

Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases.

Glenn Bauman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.